Robert L. van Nostrand - 31 Dec 2022 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Role
Director
Signature
/s/ Charles B. Haaser, attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 Dec 2022
Net transactions value
+$3,332
Form type
4
Filing time
04 Jan 2023, 14:56:11 UTC
Previous filing
03 Jan 2023
Next filing
03 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YTEN Stock Option (right to buy) Award $3,332 +2,109 $1.58 2,109 31 Dec 2022 Common Stock 2,109 $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $3,333 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the fourth quarter of 2022.